Genomics of stillbirth

Semin Perinatol. 2024 Feb;48(1):151866. doi: 10.1016/j.semperi.2023.151866. Epub 2023 Dec 19.

Abstract

Stillbirth, defined as fetal death at 20 weeks gestation or later, is a devastating pregnancy outcome affecting 1 in 175 pregnancies in the United States. Although efforts to understand the etiology of stillbirth have expanded, 25 % of cases remain unexplained and some cases previously thought to be explained may have additional unknown causative factors. Determining an etiology for stillbirth is important for clinical management and for grieving families to obtain closure, to find meaning, and to understand recurrence risks. However, the evaluation of stillbirth is not completed uniformly despite American College of Obstetrics and Gynecology (ACOG) guidelines and stillbirth data is frequently incomplete due to lack of genomic analysis, fetal autopsy, and placental pathology. Karyotype and chromosomal microarray have been the gold standard in genetic analysis in perinatal medicine for many years, but next generation sequencing holds promise towards improving diagnostic yields and providing clarity for both clinicians and patients.

Keywords: Genomics; Microarray; Sequencing; Stillbirth.

MeSH terms

  • Female
  • Fetal Death / etiology
  • Genomics
  • Humans
  • Placenta*
  • Pregnancy
  • Pregnancy Outcome
  • Stillbirth* / genetics